G. Cumbo Alexander's most recent trade in Verve Therapeutics Inc was a trade of 42,200 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Verve Therapeutics Inc | Alexander G. Cumbo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 42,200 | 42,200 | - | - | Stock Option (right to buy) | |
| Climb Bio Inc. | Alexander G. Cumbo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Climb Bio Inc. | Alexander G. Cumbo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2025 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
| Solid Biosciences Inc | Alexander G. Cumbo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 30,031 | 90,094 | - | - | Restricted Stock Units | |
| Solid Biosciences Inc | Alexander G. Cumbo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 30,031 | 72,082 (0%) | 0% | - | Common Stock | |
| Solid Biosciences Inc | Alexander G. Cumbo | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.96 per share. | 13 Feb 2025 | 11,365 | 60,717 (0%) | 0% | 4.0 | 45,005 | Common Stock |
| Solid Biosciences Inc | Alexander G. Cumbo | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 401,600 | 401,600 | - | - | Restricted Stock Units | |
| Solid Biosciences Inc | G. Alexander Cumbo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 28,612 | 57,225 | - | - | Restricted Stock Units | |
| Solid Biosciences Inc | G. Alexander Cumbo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 28,612 | 49,598 (0%) | 0% | - | Common Stock | |
| Solid Biosciences Inc | G. Cumbo Alexander | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 5.60 per share. | 02 Dec 2024 | 11,114 | 38,484 (0%) | 0% | 5.6 | 62,236 | Common Stock |
| Verve Therapeutics Inc | Alexander G. Cumbo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 136,139 | 136,139 | - | - | Stock Option (right to buy) | |
| Solid Biosciences Inc | G. Alexander Cumbo | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 240,250 | 240,250 | - | - | Employee Stock Option (Right to Buy) | |
| Solid Biosciences Inc | Alexander G. Cumbo | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 120,125 | 120,125 | - | - | Restricted Stock Units | |
| Solid Biosciences Inc | Cumbo Alexander G. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2023 | 28,612 | 85,837 | - | - | Restricted Stock Units | |
| Solid Biosciences Inc | Alexander Cumbo G. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2023 | 28,612 | 29,196 (0%) | 0% | - | Common Stock | |
| Solid Biosciences Inc | Cumbo G. Alexander | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 2.77 per share. | 02 Dec 2023 | 11,757 | 17,439 (0%) | 0% | 2.8 | 32,516 | Common Stock |
| Verve Therapeutics Inc | Alexander G. Cumbo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 26,642 | 26,642 | - | - | Stock Option (right to buy) | |
| Solid Biosciences Inc | Alexander G. Cumbo | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2022 | 228,900 | 228,900 | - | - | Stock Option (Right to Buy) | |
| Solid Biosciences Inc | Alexander G. Cumbo | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2022 | 114,449 | 114,449 | - | - | Restricted Stock Units | |
| Solid Biosciences Inc | Alexander G. Cumbo | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2022 | 584 | 584 (0%) | 0% | - | Common Stock | |
| Verve Therapeutics Inc | Alexander G. Cumbo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 31,000 | 31,000 | - | - | Stock Option (right to buy) |